Cargando…
An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
BACKGROUND: Donor acute lymphoblastic leukemia with recipient intact is a rare condition. We report a case of donor developing acute lymphoblastic leukemia 8 yrs after donating both bone marrow and peripheral blood hematopoietic stem cells. CASE PRESENTATION: This case report describes a 51-year old...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060641/ https://www.ncbi.nlm.nih.gov/pubmed/32143579 http://dx.doi.org/10.1186/s12885-020-6681-2 |
_version_ | 1783504276353449984 |
---|---|
author | Zhou, Di Xie, Ting Chen, Suning Ling, Yipeng Xu, Yueyi Chen, Bing Ouyang, Jian Yang, Yonggong |
author_facet | Zhou, Di Xie, Ting Chen, Suning Ling, Yipeng Xu, Yueyi Chen, Bing Ouyang, Jian Yang, Yonggong |
author_sort | Zhou, Di |
collection | PubMed |
description | BACKGROUND: Donor acute lymphoblastic leukemia with recipient intact is a rare condition. We report a case of donor developing acute lymphoblastic leukemia 8 yrs after donating both bone marrow and peripheral blood hematopoietic stem cells. CASE PRESENTATION: This case report describes a 51-year old female diagnosed with acute lymphoblastic leukemia who donated both bone marrow and peripheral blood stem cells 8 yrs ago for her brother with severe aplastic anemia. Whole exome sequencing revealed leukemic genetic lesions (SF3B1 and BRAF mutation) only appeared in the donor sister, not the recipient, and an unusual type of hematopoietic stem cell transplantation with the recipient’s peripheral blood stem cells was done. The patient remained in remission for 3 months before disease relapsed. CD19 CAR-T therapy followed by HLA-identical unrelated hematopoietic stem cell transplantation was applied and the patient remains in remission for 7 months till now. CONCLUSIONS: This donor leukemia report supports the hypothesis that genetic lesions happen randomly in leukemogenesis. SF3B1 combined with BRAF mutation might contribute to the development of acute lymphoblastic leukemia. |
format | Online Article Text |
id | pubmed-7060641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70606412020-03-11 An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report Zhou, Di Xie, Ting Chen, Suning Ling, Yipeng Xu, Yueyi Chen, Bing Ouyang, Jian Yang, Yonggong BMC Cancer Case Report BACKGROUND: Donor acute lymphoblastic leukemia with recipient intact is a rare condition. We report a case of donor developing acute lymphoblastic leukemia 8 yrs after donating both bone marrow and peripheral blood hematopoietic stem cells. CASE PRESENTATION: This case report describes a 51-year old female diagnosed with acute lymphoblastic leukemia who donated both bone marrow and peripheral blood stem cells 8 yrs ago for her brother with severe aplastic anemia. Whole exome sequencing revealed leukemic genetic lesions (SF3B1 and BRAF mutation) only appeared in the donor sister, not the recipient, and an unusual type of hematopoietic stem cell transplantation with the recipient’s peripheral blood stem cells was done. The patient remained in remission for 3 months before disease relapsed. CD19 CAR-T therapy followed by HLA-identical unrelated hematopoietic stem cell transplantation was applied and the patient remains in remission for 7 months till now. CONCLUSIONS: This donor leukemia report supports the hypothesis that genetic lesions happen randomly in leukemogenesis. SF3B1 combined with BRAF mutation might contribute to the development of acute lymphoblastic leukemia. BioMed Central 2020-03-06 /pmc/articles/PMC7060641/ /pubmed/32143579 http://dx.doi.org/10.1186/s12885-020-6681-2 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Zhou, Di Xie, Ting Chen, Suning Ling, Yipeng Xu, Yueyi Chen, Bing Ouyang, Jian Yang, Yonggong An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
title | An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
title_full | An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
title_fullStr | An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
title_full_unstemmed | An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
title_short | An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
title_sort | unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060641/ https://www.ncbi.nlm.nih.gov/pubmed/32143579 http://dx.doi.org/10.1186/s12885-020-6681-2 |
work_keys_str_mv | AT zhoudi anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT xieting anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT chensuning anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT lingyipeng anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT xuyueyi anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT chenbing anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT ouyangjian anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT yangyonggong anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT zhoudi unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT xieting unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT chensuning unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT lingyipeng unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT xuyueyi unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT chenbing unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT ouyangjian unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport AT yangyonggong unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport |